Clinical and Laboratory Update in Thrombosis and Anticoagulation Conference


Registration is now open for Mayo Medical Laboratories' Clinical and Laboratory Update in Thrombosis and Anticoagulation conference. The conference will be held November 18-20 at the FireSky Resort and Spa in Scottsdale, Arizona.

An estimated 37 million patients are affected by thrombotic disorders each year. This number will continue to rise with the increase in our aging population. This conference will focus on clinically applicable and cutting-edge methods used in the evaluation and treatment of patients with arterial and venous thrombotic disorders including the increasing integration of novel anticoagulants.

The laboratory evaluation of patients with congenital and acquired thrombotic disorders will be reviewed. Lectures and case studies will be presented by Mayo Clinic faculty with ample opportunity to ask questions and discuss difficult diagnostic or management issues. Case-based study questions with panel discussion will be covered throughout the conference.

Conference Objectives

  • Identify the optimal strategy to diagnose and manage venous thromboembolism
  • Employ a practical approach to evaluation and management of patients who have a transient ischemic attack or stroke
  • Describe periprocedural anticoagulation management for patients on chronic antithrombotic therapy requiring an invasive procedure
  • Define appropriate laboratory monitoring of patients receiving novel anticoagulant therapy
  • Identify a diagnostic and management plan for patients with heparin-induced thrombocytopenia
  • Recognize newer anticoagulants being used for treatment
  • Review the laboratory aspects of thrombophilia testing
  • Define the appropriate management of patients receiving novel anticoagulant therapy who are suffering from a major bleed
  • Explain the guideline-based approach to the management of atrial fibrillation, mechanical valve disease, and venous thromboembolism

Intended Audience

This program is designed for practicing clinicians, primary care providers, hematologists, cardiologists, neurologists, hospitalists, vascular medicine specialists, nurse practitioners, clinical pharmacists, physician assistants, nurses, and laboratory scientists and technologists whose practices and interests include aspects of thrombotic disorders.

Conference Faculty

Course Directors

mcbane (1)

Robert McBane, M.D.

Consultant, Division of Cardiovascular Diseases
Department of Internal Medicine
Professor of Medicine, Mayo Clinic College of Medicine
Mayo Clinic, Rochester, Minnesota


Rajiv Pruthi, M.B.B.S. 
Consultant, Hematology/Internal Medicine and Laboratory Medicine
Mayo Coagulation Clinic, Hemophilia Center and Special Coagulation Laboratory
Director, Mayo Comprehensive Hemophilia Center
Co-Director, Mayo Special Coagulation Laboratory and DNA Diagnostic Laboratory
Co-Director, Coagulation Clinical and Laboratory Practice
Associate Professor, Mayo Clinic College of Medicine
Mayo Clinic, Rochester, Minnesota

Click here to see a full list of conference faculty.


$530-Physicians / Scientists
$397 -Residents / Fellows / Allied Health

The registration fee includes tuition, conference syllabus (accessible online/downloadable), breakfasts, lunches, break refreshments, and Wednesday evening reception. Although it is not Mayo Medical Laboratories Education Department’s policy to limit the number of registrants for a conference, room facilities may necessitate closing of enrollment; therefore, early registration is strongly advised. Please do not finalize hotel or travel arrangements until you receive written notification. Registration deadline is October 26, 2015.


Kelley Schreiber

Kelley Schreiber is a Marketing Channel Manager at Mayo Medical Laboratories. She is the principle editor and writer of Insights and leads social media and direct marketing strategy. Kelley has worked at Mayo Clinic since 2013. Outside of work, you can find Kelley running, traveling, playing with her new kitten, and exploring new foods.